Gentel Biosciences

Gentel obtains worldwide exclusive license from PriTest® to enhance corporate IP in protein microarray field

The advantages of Gentel’s accumulated intellectual property around nitrocellulose surface chemistry are substantial, as it offers unparalleled sensitivity and dynamic range for protein microarray applications.

“The acquisition of this additional intellectual property means we can continue to push the limits of protein microarray technology for years to come”, says Alex Vodenlich, President and CEO for Gentel.

Gentel supplies its Protein Microarray Slides to a number of industry leading OEM partners, in addition to researchers who create their own content-based protein arrays. Gentel also uses the proprietary ultra-thin nitrocellulose surface chemistry in the SilverQuant® Cancer Biomarker Array Kit and in its Sample Testing and Custom Services businesses.

About PriTest Inc.

PriTest has developed breakthrough diagnostic tests for tuberculosis infection: TBfree™ for Mycobacterium tuberculosis testing in people, and SeraLyte-Mbv™ for Mycobacterium bovis testing of livestock. Our easy-to-use pathogen detection system offers a combination of speed and sensitivity not found on the market today.